🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A Gut Feeling: Dr. Roger McIntyre's 20 Year Journey of Research on GLP-1 x.com/i/broadcasts/1…

Day 1 of NEI Spring Congress made one thing was clear: this community’s passion for lifelong learning is truly unmatched. Thank you for bringing your questions, insights, and energy, — we’re just getting started. 💡 #NEICongress

2025 NEI Spring Congress kicked off last Wednesday, May 7, with a special presentation by the meeting chair, Dr. Roger McIntyre (Roger S. McIntyre, MD, FRCPC). Joined by Dr. Andrew Cutler, they shared insights from 20 years of groundbreaking research on Glucagon-like peptide-1 (GLP-1). Read

During the 2025 NEI Spring Congress, Dr. Thomas Schwartz explored the complexities of dissociative disorders in a highly anticipated new session. Read more: nei.global/21036

Join us at NEI Booth 1539 on Monday, May 19 during the 2025 APA Annual Meeting! Whether you're a longtime listener of the #NEIPodcast or just discovering it, stop by and say hello! #APA2025 #APAAM25

Thank you to everyone who visited the NEI Booth at APA in Los Angeles! It’s always a privilege to connect with those passionate about mental health. Your insights inspire our work, and we’re excited to keep growing together. Stay connected — visit our website to learn more about

This special episode includes extended Q&A sessions that address your unanswered questions from presentations delivered at the 2025 Spring Congress– featuring NEI Faculty Dr. Andrew Cutler, Desiree Matthews, Dr. Raj Mago, and Hara Oyedeji Listen now ➡️ nei.global/e255

Brexpiprazole, a serotonin-dopamine activity modulator already approved for adult schizophrenia, has now demonstrated efficacy and safety in adolescents in the first placebo-controlled trial of its kind. Read more: nei.global/21043

As May comes to an end, so does Mental Health Awareness Month. We extend our heartfelt thanks to all the mental health providers, advocates, and educators making a difference. Your work matters. Let’s continue building a supportive, stigma-free world. Stay informed with all the

A new recent, phase 3 proof-of-concept trial offers early evidence that solriamfetol may have therapeutic benefit for a subset of individuals with major depressive disorder (MDD) who also experience excessive daytime sleepiness. Read more nei.global/21045

In this episode of the NEI Podcast, Dr. Andy Cutler speaks with Dr. Katharine Phillips about recognizing and managing body dysmorphic disorder (BDD). Tune in as they explore the clinical presentation of BDD, available treatment options, and strategies clinicians can use to

The U.S. Food and Drug Administration (FDA) has approved the first blood-based test to help diagnose Alzheimer’s disease. Read more: nei.global/21044

The 2025 NEI Fall Congress Scientific Poster Session is now accepting abstracts – one of the most anticipated events in mental healthcare! Share your research, connect with professionals, and amplify your impact in the field. 🔗 Submit Your Abstract: nei.global/25fallposters 🗓

A new randomized controlled trial directly compared the brain effects of psilocybin-assisted therapy and escitalopram, a commonly prescribed SSRI, in patients with moderate-to-severe major depressive disorder. Read more nei.global/21051

As depression remains a significant public health concern, it's essential for clinicians to stay updated on advanced, evidence-based treatment approaches. Join us this Saturday, June 28, for a complimentary half-day CME/CE program that dives into two often-overlooked areas:

NEI Saturday Morning Live is starting NOW! 🔗 nei.global/25sml-jun28 Log in to join Drs. Roger McIntyre and Mark Zimmerman as they explore two often-overlooked topics: difficult-to-treat depression (DTD) and anhedonia. Not registered yet? There’s still time! It’s free, but

In this episode of the NEI Podcast, Dr. Andy Cutler sits down with Dr. Jeffrey Strawn to unpack the complexities of obsessive-compulsive disorder (OCD)—from identifying symptoms to navigating treatment options. Tune in for an enlightening discussion! 🔗 nei.global/e258

Although maternal perinatal mental health has been widely studied, the effects of paternal depression, anxiety, and stress on child development have been largely overlooked. A recent comprehensive systematic review and meta-analysis explored how paternal mental distress from

1 in 4 healthcare workers struggle with insomnia— and shift work, COVID-19 aftereffects, and anxiety are making it worse. A recent study explored the prevalence and key factors contributing to this growing issue among healthcare workers. Read more: nei.global/21064

If GLP-1 is not an option, what else can decrease inflammation? Here Dr. Roger McIntyre Roger S. McIntyre, MD, FRCPC Here, discusses different methods to decrease inflammation. Watch the full presentation for by creating a free guest account: nei.global/mcintyre-encor…